News from IDF Europe

Call for venue: 2014 IDF Europe Youth Leadership Camp

This year, and following the success of the past 3 camps, IDF Europe wishes to continue working closely with Member Associations on the 4th edition of its Youth Leadership Camp to be held next Summer.

IDF Europe study on Access to Quality Medecines & Medical Devices for Diabetes Care in Europe now online!

EConDA project website launched

The website for the EConDA project, of which IDF Europe is partner, was launched today.

High number of people with diabetes in Europe receiving inadequate care

Prof Assal and Dr Lukacs win 2013 IDF Europe Prizes in Diabetes

Professor Jean-Philippe Assal  and Doctor Krisztina Lukacs were presented with the 2013 IDF Europe Prize in Diabetes at an award ceremony at the European Parliament in Brussels today.

Diabetes awareness week kicks off today in European Parliament

Diabetes awareness week kicks off today in the European Parliament in Brussels, coinciding with World Diabetes Day which is celebrated each year on 14 November. Hosted by Sarah Ludford MEP in collaboration with IDF Europe, the week aims at raising awareness of the diabetes epidemic through a series of initiatives.

New issue of Treatment Strategies - Diabetes now online!

The latest issue of Treatment Strategies - Diabetes is now available online.

The Latest IDF Europe News Update is here!

Our latest IDF Europe News Update is here!

Batches of the insulin medicine NovoMix 30 FlexPen and Penfill to be recalled

Patients using medicine from the affected batches should be switched to products from unaffected batches or alternative treatment

The European Medicines Agency is giving recommendations on how to deal with a recall of some batches of the diabetes medicine NovoMix 30 FlexPen and Penfill. The affected batches are being recalled because of a manufacturing problem during the filling of the cartridges, which resulted in some batches of NovoMix 30 containing too high or too low amounts of insulin units per millilitre.

European Union introduces black triangle symbol for medicines under additional monitoring

The European Union (EU) has introduced a new process to label medicines that are being monitored particularly closely by regulatory authorities. These medicines are described as being under 'additional monitoring'.

Pages